These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum stability of 67Cu chelates: comparison with 111In and 57Co. Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK Int J Rad Appl Instrum B; 1986; 13(4):363-8. PubMed ID: 3539884 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. Deshpande SV; Subramanian R; McCall MJ; DeNardo SJ; DeNardo GL; Meares CF J Nucl Med; 1990 Feb; 31(2):218-24. PubMed ID: 2107283 [TBL] [Abstract][Full Text] [Related]
4. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative. Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442 [TBL] [Abstract][Full Text] [Related]
5. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465 [TBL] [Abstract][Full Text] [Related]
6. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity. Kozak RW; Raubitschek A; Mirzadeh S; Brechbiel MW; Junghans RP; Gansow OA; Waldmann TA Cancer Res; 1989 May; 49(10):2639-44. PubMed ID: 2785435 [TBL] [Abstract][Full Text] [Related]
7. Use of new heterobifunctional reagent for radiometallic labeling of antibodies. Wang TS; Ng AK; Alsedairy S; Fawwaz RA; Hardy MA; Alderson PO NCI Monogr; 1987; (3):145-8. PubMed ID: 3821912 [TBL] [Abstract][Full Text] [Related]
8. Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice. Deshpande SV; DeNardo SJ; Meares CF; McCall MJ; Adams GP; Moi MK; DeNardo GL J Nucl Med; 1988 Feb; 29(2):217-25. PubMed ID: 3258025 [TBL] [Abstract][Full Text] [Related]
9. A new radiochemical method to determine the stability constants of metal chelates attached to a protein. Subramanian KM; Wolf W J Nucl Med; 1990 Apr; 31(4):480-8. PubMed ID: 2109050 [TBL] [Abstract][Full Text] [Related]
10. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood. Kinuya S; Jeong JM; Garmestani K; Saga T; Camera L; Brechbiel MW; Gansow OA; Carrasquillo JA; Neumann RD; Paik CH J Nucl Med; 1994 Nov; 35(11):1851-7. PubMed ID: 7965168 [TBL] [Abstract][Full Text] [Related]
11. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability]. Sun B Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218 [TBL] [Abstract][Full Text] [Related]
12. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging. Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971 [TBL] [Abstract][Full Text] [Related]
15. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates. Lewis MR; Raubitschek A; Shively JE Bioconjug Chem; 1994; 5(6):565-76. PubMed ID: 7873659 [TBL] [Abstract][Full Text] [Related]
17. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates. Paxton RJ; Jakowatz JG; Beatty JD; Beatty BG; Vlahos WG; Williams LE; Clark BR; Shively JE Cancer Res; 1985 Nov; 45(11 Pt 2):5694-9. PubMed ID: 4053042 [TBL] [Abstract][Full Text] [Related]
18. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Kukis DL; Diril H; Greiner DP; DeNardo SJ; DeNardo GL; Salako QA; Meares CF Cancer; 1994 Feb; 73(3 Suppl):779-86. PubMed ID: 8306260 [TBL] [Abstract][Full Text] [Related]
20. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]